| Issue Date | Title | Author(s) |
| 2017 | Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer A Consensus Statement From the China Cooperative Group of Cryosurgery on Pancreatic Cancer, International Society of Cryosurgery, and Asian Society of Cryosurgery | He, Lihua; Niu, Lizhi; Korpan, Nikolai N.; Sumida, Sajio; Xiao, Yueyong; Li, Jiaping; Sutedja, Barlian; Lu, Youyong; Zuo, Jiansheng; Liu, Jianguo; Xu, Kecheng |
| Jun-2020 | Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study | Wang, Zhexuan; Wang, Enxin; Bai, Wei; Xia, Dongdong; Ding, Rong; Li, Jiaping; Wang, Qiuhe; Liu, Lei; Sun, Junhui; Mu, Wei; Zhao, Hui; Pan, Xingnan; Shao, Guoliang; Zhu, Xiaoli; Yin, Guowen; Shi, Haibin; Wu, Jianbing; Lin, Zhengyu; Yang, Shufa; Liu, Jueshi; Wang, Wenhui; Zhu, Xu; Lv, Yong; Li, Jing; Chen, Hui; Wang, Wenjun; Li, Kai; Yuan, Xulong; Yu, Tanlei; Yuan, Jie; Li, Xiaomei; Niu, Jing; Yin, Zhanxin; Xia, Jielai; Fan, Daiming; Han, Guohong |
| 2019 | Identifying optimal candidates for combining transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma: A multicenter observational study | Wang, Enxin; Bai, Wei; Wang, Zhexuan; Xia, Dongdong; Wang, Qiuhe; Huang, Ming; Sun, Junhui; Mu, Wei; Zhao, Hui; Pan, Xingnan; Shao, Guoliang; Zhu, Xiaoli; Yin, Guowen; Shi, Haibin; Wu, Jianbing; Li, Jiaping; Lin, Zhengyu; Yang, Shufa; Liu, Jueshi; Wang, Wenhui; Zhu, Xu; Ding, Rong; Lv, Yong; Chen, Hui; Li, Kai; Niu, Jing; Yin, Zhanxin; Xia, Jielai; Fan, Daiming; Han, Guohong |
| Jul-2022 | Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study | Xia, Dongdong; Bai, Wei; Wang, Enxin; Li, Jiaping; Chen, Xiaoming; Wang, Zhexuan; Huang, Mingsheng; Huang, Ming; Sun, Junhui; Yang, Weizhu; Lin, Zhengyu; Wu, Jianbing; Li, Zixiang; Yang, Shufa; Zhu, Xu; Chen, Zaizhong; Zhang, Yanfang; Fan, Wenzhe; Mai, Qicong; Ding, Rong; Nie, Chunhui; Feng, Long; Li, Xueda; Huang, Wukui; Sun, Jun; Wang, Qiuhe; Lv, Yong; Li, Xiaomei; Luo, Bohan; Wang, Zhengyu; Yuan, Jie; Guo, Wengang; Li, Kai; Li, Bing; Li, Ruijun; Yin, Zhanxin; Xia, Jielai; Han, Guohong |
| 5-Sep-2022 | OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism | Wen, Jie; Aili, Abudureyimujiang; Yan, Yao Xue; Lai, YuLin; Niu, Shaoqing; He, Shasha; Zhang, Xiaokai; Zhang, Guixiong; Li, Jiaping |
| 26-Oct-2022 | OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism (vol 12, 977348, 2022) | Wen, Jie; Aili, Abudureyimujiang; Yan, Yao Xue; Lai, YuLin; Niu, Shaoqing; He, Shasha; Zhang, Xiaokai; Zhang, Guixiong; Li, Jiaping |
